<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=316298&amp;fmt=gif">
Breast Cancer Awareness Month
Breast Cancer Awareness Month
Awareness
to
Action
October is a month dedicated to raising breast cancer awareness. At Color, we believe in turning awareness into action, especially as we navigate the COVID-19 crisis.
Breast Cancer by the Numbers
<div id="hs_cos_wrapper_module_1602263294991151_" class="hs_cos_wrapper hs_cos_wrapper_widget hs_cos_wrapper_type_inline_text" style="" data-hs-cos-general-type="widget" data-hs-cos-type="inline_text" data-hs-cos-field="column1_text">Approximately 1 in 8 women (12.5%) will develop breast cancer in their lifetime.</div>
1 in 8 women
Approximately 1 in 8 women (12.5%) will develop breast cancer in their lifetime.
<div id="hs_cos_wrapper_module_1602263294991151_" class="hs_cos_wrapper hs_cos_wrapper_widget hs_cos_wrapper_type_inline_text" style="" data-hs-cos-general-type="widget" data-hs-cos-type="inline_text" data-hs-cos-field="column2_text">Hereditary cancers are caused by inherited genetic mutations.</div>
10-15% of most cancers are hereditary1, 2, 3, 4
Hereditary cancers are caused by inherited genetic mutations.
<div id="hs_cos_wrapper_module_1602263294991151_" class="hs_cos_wrapper hs_cos_wrapper_widget hs_cos_wrapper_type_inline_text" style="" data-hs-cos-general-type="widget" data-hs-cos-type="inline_text" data-hs-cos-field="column3_text">Breast cancer survival rates increase from 25% to 98% when caught early.</div>
Early detection saves lives6
Breast cancer survival rates increase from 25% to 98% when caught early.
Cancer Care During COVID-19
<div id="hs_cos_wrapper_module_160247298588927_" class="hs_cos_wrapper hs_cos_wrapper_widget hs_cos_wrapper_type_inline_text" style="" data-hs-cos-general-type="widget" data-hs-cos-type="inline_text" data-hs-cos-field="column1_text">This summer, weekly cancer screening volumes for breast, colon and cervical cancer were as much as 36% lower than their pre-COVID-19 levels.<sup><a href="#bcamReferences">6</a></sup></div>
COVID-19 has interrupted traditional preventative measures.
This summer, weekly cancer screening volumes for breast, colon and cervical cancer were as much as 36% lower than their pre-COVID-19 levels.6
<div id="hs_cos_wrapper_module_160247298588927_" class="hs_cos_wrapper hs_cos_wrapper_widget hs_cos_wrapper_type_inline_text" style="" data-hs-cos-general-type="widget" data-hs-cos-type="inline_text" data-hs-cos-field="column2_text">Over the next 10 years, there could be up to 10,000 additional deaths from breast and colorectal cancer alone, due to missed screenings during the pandemic.<sup><a href="#bcamReferences">7</a></sup> <br><a href="https://www.color.com/awareness-to-action-navigating-breast-cancer-care-during-the-covid-19-pandemic">Read more here</a> on how to stay current with your screenings during the pandemic.</div>
COVID-19 could reverse falling cancer mortality rates.
Over the next 10 years, there could be up to 10,000 additional deaths from breast and colorectal cancer alone, due to missed screenings during the pandemic.7 
Read more here on how to stay current with your screenings during the pandemic.
Prevention comes from action.
Clinical-grade genetics you can count on.
Unlike recreational genetic tests, Color’s precision health program offers clinical results, genetic counseling services, and actionable next steps.*
*The Color test does not diagnose cardiovascular disease. It is a physician-ordered test that can provide information about your risk for common hereditary heart conditions. Knowing your genetic risk can help you and your doctor develop a personalized screening and prevention plan.
All of Us
NIH Awards Color $4.6 million to provide Genetic Counseling for million-person study.
NorthShore
NorthShore patients get access to Color as part of preventive care.
Clinical OMICS
All women over 30 should consider testing for gene mutations.
Awareness is just the first step
Observe Breast Cancer Awareness Month by taking preventative action.
Learn More
×

Join our newsletter

References
  1. Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. January 2015;121(1):25-33.
  2. Pal T, Permuth-Wey J, Betts JA, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. December 2005;104(12):2807-16.
  3. Claus EB, Risch N, Thompson WD, et al. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat. November 1993;28(2):115-20.
  4. Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. March 2001;68(3):700-10.
  5. SEER Stat Fact Sheets: Breast Cancer. Published November 2013. National Cancer Institute.
  6. Mast C. and Munoz del Rio A. Delayed Cancer Screenings—A Second Look. Epic Health Research Network website. July 17, 2020. Accessed October 5, 2020.
  7. Sharpless NE. COVID-19 and cancer. Science. June 2020;368(6497):1290.